Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0001415889-25-022121·Atlas Venture Fund X, L.P.
Schedule 13D ownership disclosure
Disc Medicine Inc
Common Stock, $0.0001 par value per share · CUSIP: 254604101
Event date: 2025-08-13
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Atlas Venture Fund X, L.P.Reported CIK 0001628098
Shares: 1,084,527.00 · Class: 3.1%
- ATLAS VENTURE ASSOCIATES X, L.P.Reported CIK 0001742766
Shares: 1,084,527.00 · Class: 3.1%
- Atlas Venture Associates X, LLCReported CIK 0001742765
Shares: 1,084,527.00 · Class: 3.1%
- Atlas Venture Fund XII, L.P.Reported CIK 0001812049
Shares: 51,000.00 · Class: 0.1%
- Atlas Venture Associates XII, L.P.Reported CIK 0001845875
Shares: 51,000.00 · Class: 0.1%
- Atlas Venture Associates XII, LLCReported CIK 0001845871
Shares: 51,000.00 · Class: 0.1%
- Atlas Venture Opportunity Fund I, L.P.Reported CIK 0001759241
Shares: 592,908.00 · Class: 1.7%
- Atlas Venture Associates Opportunity I, L.P.Reported CIK 0001780065
Shares: 592,908.00 · Class: 1.7%
- Atlas Venture Associates Opportunity I, LLCReported CIK 0001780066
Shares: 592,908.00 · Class: 1.7%
- Atlas Venture Opportunity Fund II, L.P.Reported CIK 0001885327
Shares: 420,549.00 · Class: 1.2%
- Atlas Venture Associates Opportunity II, LPReported CIK 0001935814
Shares: 420,549.00 · Class: 1.2%
- Atlas Venture Associates Opportunity II, LLCReported CIK 0001935810
Shares: 420,549.00 · Class: 1.2%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001415889-25-022121
- Form type
- SCHEDULE 13D/A
- Filer
- Atlas Venture Fund X, L.P.
- CIK
- CIK 1628098
- Filed
- Aug 15, 2025
- Reporting period
- Aug 13, 2025
- Description
- Schedule 13D beneficial ownership